A live-action Helldivers movie is on the horizon, but recent news has stirred up the fanbase. The CEO of Arrowhead Game Studios is now asking fans to trust the process, particularly the film’s ...

Following the announcement that Fast & Furious’ Justin Lin will be helming the upcoming Helldivers movie adaptation, Shams Jorjani, CEO of Arrowhead Studios, has responded to criticism from fans over ...

The CEO of Helldivers 2 developer Arrowhead has responded to fan concern about the choice of Justin Lin as the director of the Helldivers movie, after it emerged he leaned into not being a gamer for ...

The Helldivers movie is making progress almost a year after being announced, but there is one thing that's already troubling fans. Director Justin Lin, who has previously helmed multiple Fast and ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

The Chiefs continue to move toward an inevitable decision between renovating Arrowhead Stadium and building a new stadium. On Monday, Chiefs owner Clark Hunt addressed the status of the team’s effort ...

Among the quiet pines above Lake Arrowhead, a battle is underway, one that will decide who calls the shots in the unincorporated community nestled in the San Bernardino Mountains. In 1915, property ...

Sept 11 (Reuters) - Ionis Pharmaceuticals (IONS.O), opens new tab sued biotech rival Arrowhead Pharmaceuticals (ARWR.O), opens new tab for patent infringement in California federal court on Thursday ...

Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis' claim that Arrowhead's potential rival to Tryngolza breaches a patent. Arrowhead claims ...

The announcement of a landmark deal with a pharmaceutical giant validates Arrowhead's technology. For reference, the TRiM platform is a key part of the investment case for the stock. Arrowhead's ...